Algorithm of Femoropopliteal Endovascular Treatment.

Medicina (Kaunas) · 2022 · PMC9501396 · PMID 36143968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The randomized Zilver PTX trial showed a trend towards better patency at 5 years in the drug-eluting-stent (DES) and preparation group versus the DES without preparation group (72.4 vs. 64.9%) [ 21 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.